These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21986028)

  • 21. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology.
    Zhang L; Peeples ME; Boucher RC; Collins PL; Pickles RJ
    J Virol; 2002 Jun; 76(11):5654-66. PubMed ID: 11991994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccine development: memorandum from a joint WHO/NIAID meeting.
    Murphy BR; Collins PL
    Bull World Health Organ; 1997; 75(4):307-13. PubMed ID: 9342889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shift in Clinical Epidemiology of Human Parainfluenza Virus Type 3 and Respiratory Syncytial Virus B Infections in Korean Children Before and During the COVID-19 Pandemic: A Multicenter Retrospective Study.
    Kim YK; Song SH; Ahn B; Lee JK; Choi JH; Choi SH; Yun KW; Choi EH
    J Korean Med Sci; 2022 Jul; 37(28):e215. PubMed ID: 35851860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys.
    Tang RS; Mahmood K; Macphail M; Guzzetta JM; Haller AA; Liu H; Kaur J; Lawlor HA; Stillman EA; Schickli JH; Fouchier RA; Osterhaus AD; Spaete RR
    Vaccine; 2005 Feb; 23(14):1657-67. PubMed ID: 15705469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parainfluenza virus 5 (PIV5) amplifying virus-like particles expressing respiratory syncytial virus (RSV) antigens protect mice against RSV infection.
    Huertas-Díaz MC; Phan S; Elson A; Nuñez I; Wei H; Sakamoto K; He B
    Vaccine; 2019 May; 37(22):2925-2934. PubMed ID: 31010715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4.
    Templeton KE; Scheltinga SA; Beersma MF; Kroes AC; Claas EC
    J Clin Microbiol; 2004 Apr; 42(4):1564-9. PubMed ID: 15071005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
    Ohol YM; Wang Z; Kemble G; Duke G
    PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
    Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replication of parainfluenza type-3 virus and bovine respiratory syncytial virus in isolated bovine type-II alveolar epithelial cells.
    Castleman WL; Northrop PJ; McAllister PK
    Am J Vet Res; 1991 Jun; 52(6):880-5. PubMed ID: 1652906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bovine parainfluenza virus type 3 (PIV3) expressing the respiratory syncytial virus (RSV) attachment and fusion proteins protects hamsters from challenge with human PIV3 and RSV.
    Haller AA; Mitiku M; MacPhail M
    J Gen Virol; 2003 Aug; 84(Pt 8):2153-2162. PubMed ID: 12867647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue.
    Palmer SG; Porotto M; Palermo LM; Cunha LF; Greengard O; Moscona A
    mBio; 2012; 3(3):. PubMed ID: 22669629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after respiratory syncytial virus and parainfluenza virus infection.
    Radi ZA; Meyerholz DK; Ackermann MR
    Viral Immunol; 2010 Feb; 23(1):43-8. PubMed ID: 20121401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative proteome profiling of respiratory virus-infected lung epithelial cells.
    van Diepen A; Brand HK; Sama I; Lambooy LH; van den Heuvel LP; van der Well L; Huynen M; Osterhaus AD; Andeweg AC; Hermans PW
    J Proteomics; 2010 Aug; 73(9):1680-93. PubMed ID: 20470912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respiratory syncytial virus interaction with human airway epithelium.
    Villenave R; Shields MD; Power UF
    Trends Microbiol; 2013 May; 21(5):238-44. PubMed ID: 23523320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA.
    Atreya PL; Kulkarni S
    Virology; 1999 Sep; 261(2):227-41. PubMed ID: 10497108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status of vaccines for parainfluenza virus infections.
    Sato M; Wright PF
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S123-5. PubMed ID: 18820572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children.
    Belshe RB; Newman FK; Anderson EL; Wright PF; Karron RA; Tollefson S; Henderson FW; Meissner HC; Madhi S; Roberton D; Marshall H; Loh R; Sly P; Murphy B; Tatem JM; Randolph V; Hackell J; Gruber W; Tsai TF
    J Infect Dis; 2004 Dec; 190(12):2096-103. PubMed ID: 15551207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection.
    Spriggs MK; Collins PL; Tierney E; London WT; Murphy BR
    J Virol; 1988 Apr; 62(4):1293-6. PubMed ID: 2831389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is parainfluenza virus a threatening virus for human cancer cell lines?
    Danjoh I; Sone H; Noda N; Iimura E; Nagayoshi M; Saijo K; Hiroyama T; Nakamura Y
    Hum Cell; 2009 Aug; 22(3):81-4. PubMed ID: 19624309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rescue of dual reporter-tagged parainfluenza virus 5 as tool for rapid screening of antivirals in vitro.
    Liu F; Wang Q; Shan H
    Vet Microbiol; 2021 Aug; 259():109154. PubMed ID: 34237497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.